SlideShare a Scribd company logo
HYPERTENSION
Principle of Drug Therapy
Mohammad Ilyas, M.D.
Assistant Clinical Professor
University of Florida / Health Sciences Center
Jacksonville, Florida USA
1
Why Treat HTN?
All Symptomatic patients, treatment is Mandatory:
Damage to the vascular epithelium, paving the path for
atherosclerosis (IHD, CVA) or nephropathy due to high
intra-glomerular pressure
Reduction of the blood pressure by 5 mmHg can
decrease the risk of stroke by 34%, of ischaemic heart
disease by 21%.
Hypertension, even asymptomatic needs treatment
2
Types of
Hypertension
Essential Secondary
A disorder of unknown origin affecting the
Blood Pressure regulating mechanisms
Secondary to other disease processes
Environmental
Factors
Stress Na+ Intake Obesity Smoking
3
Risk factors for CVD
1. Age above 55 and 65 in Men and Woman respectively
2. Family History
3. Smoking
4. DM and Dyslipidemia
5. Hypertension
6. Obesity
7. Microalbuminuria
4
JNC 7 (2003) Hypertension Classification and Management
5
JAMA. 2013;():. doi:10.1001/jama.2013.284427
JNC 8 (2014 Hypertension Guideline Management Algorithm)
2
6
JAMA. 2013;():. doi:10.1001/jama.2013.284427
JNC 8 (2014 Hypertension Guideline Management Algorithm)
7
Blood Pressure Regulation
 Blood Pressure = Cardiac output (CO) X Resistance to passage
of blood through pre-capillary arterioles (PVR)
 Physiologically CO and PVR is maintained minute to minute by –
arterioles (1) post-capillary venules (2) and Heart (3)
 Kidney is the fourth site – volume of intravascular fluid
 Baroreflex, humoral mechanism and renin-angiotensin-
aldosterone system regulates the above 4 sites
 Local agents like Nitric oxide
 In hypertensives – Baroreflex and renal blood-volume control
system – set at higher level
 All antihypertensives act via interfering with normal mechanisms
8
9
Baroreceptor reflex arc
 Postural baroreflex:
10
The Renal response
 Long-term blood pressure control – by controlling blood volume
 Reduction in renal pressure - intrarenal redistribution of pressure
and increased absorption of salt and water
 Decreased pressure in renal arterioles and sympathetic activity –
renin production – angiotensin II production
 Angiotensin II:
Causes direct constriction of renal arterioles
Stimulation of aldosterone synthesis – sodium absorption and
increase in intravascular blood volume
11
12
Start one drug, titrate to maximum dose, and
then add a second drug
Start one drug and then add a second drug
before achieving maximum dose of the
initial drug
Begin with 2 drugs at the same time, either as 2
separate pills or as a single pill combination
Strategies to Dose of Antihypertensive Drugs13
Principle of Pharmacologic Therapy
Initial mono-therapy in uncomplicated hypertension
Thiazide diuretics, long-acting calcium channel blockers and ACE
inhibitors or angiotensin II receptor blockers.
Beta blockers are not commonly used for initial mono therapy in
the absence of a specific indication
Combination therapy - with drugs from different classes
has a substantially greater blood pressure lowering effect
than doubling the dose of a single agent.
14
Pre-hypertension
Individuals who are pre-hypertensive are not
candidates for drug therapy but
 Should be firmly and unambiguously advised to
practice lifestyle modification
Those with pre-HTN, who also have diabetes or kidney
disease, drug therapy is indicated if a trial of lifestyle
modification fails to reduce their BP to 130/80 mmHg
or less.
15
Isolated Systolic Hypertension
Not distinguished as a separate entity as far as
management is concerned.
SBP should be primarily considered during treatment
and not just diastolic BP.
Systolic BP is more important cardiovascular risk
factor after age 50.
Diastolic BP is more important before age 50.
16
Frequency Distribution of Untreated HTN by Age17
Isolated Systolic
HTN
Isolated Diastolic
HTN
Systolic Diastolic
HTN
Treatment of Hypertension
7 compelling Indications:
Heart failure
Coronary artery disease
H/o MI
H/o stroke
Diabetes
Chronic Renal failure
18
You must know
 Classification of Antihypertensive
 Antihypertensive mechanisms:
Diuretics, ACE inhibitors, ARBs, Beta-blockers, alpha-blockers,
CCBs, Vasodilators and central sympatholytics
 Pateint status of Drugs
 Preparation and dosage of commonly used drugs.
 Common Adverse effects of Drugs
19
General principles
Stage I:
Start with a single most appropriate drug with a low dose.
Preferably start with Thiazides. Others like beta-blockers, CCBs,
ARBs and ACE inhibitors may also be considered. CCB – in
case of elderly and stroke prevention. If required increase the
dose moderately
Partial response or no response – add from another group of
drug, but remember it should be a low dose combination
If not controlled – change to another low dose combination
In case of side effects lower the dose or substitute with other
group
Stage 2: Start with 2 drug combination – one should be
diuretic
20
Combination therapy
 In clinical practice a large number of patients require
combination therapy – the combination should be rational and
from different patterns of haemodynamic effects
Sympathetic inhibitors (not beta-blockers) and vasodilators + diuretics
Diuretics, CCBs, ACE inhibitors and vasodilators + beta blockers
(blocks renin release)
Hydralazine and CCBs + beta-blockers (tachycardia countered)
ACE inhibitors + diuretics
 3 (three) Drug combinations: CCB+ACE/ARB+diuretic; CCB+Beta
blocker+ diuretic; ACEI/ARB+ beta blocker+diuretic
21
Principle of Combination
 Never combine:
Alpha or beta blocker and clonidine - antagonism
Nifedepine and diuretic synergism
Hydralazine with prazosin
Diltiazem and verapamil with beta blocker – bradycardia
Methyldopa and clonidine
 Hypertension and pregnancy:
No drug is safe in pregnancy
Avoid diuretics, propranolol, ACE inhibitors, Sodium nitroprusside etc
Safer drugs: Hydralazine, Methyldopa, cardioselective beta blockers
and prazosin
22
Nocturnal therapy
 The average nocturnal blood pressure is approximately 15
percent lower than daytime values.
 Failure of the blood pressure to fall by at least 10 percent
during sleep is called "non-dipping," and is a stronger
predictor of adverse cardiovascular outcomes than daytime
blood pressure.
 Shifting at least one antihypertensive medication from the
morning to the evening both may restore the normal
nocturnal blood pressure dip, and reduces 24-hour mean
blood pressure.
 Nocturnal antihypertensive therapy may reduce the
incidence of cardiovascular disease
23
Resistant hypertension
Resistance is usually defined as a diastolic blood pressure
above 90 mmHg despite intake of three or more
antihypertensive medications including a diuretic.
 Suboptimal therapy
 Extracellular volume expansion
 Poor compliance with medical or dietary therapy
 Identifiable or secondary hypertension
 Office or "white coat" hypertension
 Ingestion of substances that can elevate the blood
pressure
24
Individualizing antihypertensive therapy
Indication Antihypertensive drugs
Systolic heart failure
ACE inhibitor or ARB, beta blocker,
diuretic, aldosterone antagonist*
Post-myocardial infarction
ACE inhibitor, beta blocker,
ARB, aldosterone antagonist
Proteinuric kidney disease ACE inhibitor and/or ARB
Angina pectoris
Beta blocker, calcium channel
blocker
Atrial fibrillation rate control
Beta blocker, non-dihydropyridine
calcium channel blocker
Atrial flutter rate control
Beta blocker, non-dihydropyridine
calcium channel blocker
25
Individualizing antihypertensive therapy
Benign prostatic hyperplasia Alpha blocker
Essential tremor
Beta blocker
(noncardioselective)
Hyperthyroidism Beta blocker
Migraine
Beta blocker, calcium
channel blocker
Osteoporosis Thiazide diuretic
Raynaud's syndrome
Dihydropyridine calcium
channel blocker
26
Contraindications
Angioedema ACE inhibitor
Bronchospastic disease Beta blocker
Depression Reserpine
Liver disease Methyldopa
Pregnancy (or at risk for) ACE inhibitor, ARB, renin inhibitor
Second or third degree heart
block
Beta blocker, non-
dihydropyridine calcium channel
blocker
27
Adverse effect
Depression Beta blocker, central alpha-2 agonist
Gout Diuretic
Hyperkalemia
Aldosterone antagonist, ACE inhibitor,
ARB, renin inhibitor
Hyponatremia Thiazide diuretic
Renovascular disease ACE inhibitor, ARB, or renin inhibitor
28
Discontinuing therapy
 If the BP is well control on monotherapy
 55 % of patients remain normotensive for at least one to two years
 More gradual tapering of drug dose is indicated in well-controlled
patients taking multiple drugs
 Abrupt cessation of therapy with a short-acting beta-blocker (such
as propranolol) or the short-acting alpha-2-agonist clonidine can
lead to a potentially fatal withdrawal syndrome.
 Gradual discontinuation of these agents over a period of weeks
should prevent this problem.
29
Pearls
The only thiazide that will work with an elevated creatinine is
metolazone (zaroxolyn)
If creatinine is elevated than use a loop diuretic
If potassium is elevated, evaluate current meds and use a
diuretic
If potassium is low – ask why
If edema present – and ask why
Elderly patients benefit from blood pressure management
Black patients benefit from ACE/ARB – may need to use larger
doses to obtain BP lowering effect
30
Pearls Cont.
Metabolic acidosis and hyperkalemai?
Take blood pressure periodically lying and
standing so as not to miss supine (orthostatic)
hypertension associated with autonomic
insufficiency – this is treated differently
31
Treatment failure – Why ?
“Drugs don’t work in patients who
don’t take them”
C. Everett Koop, MD, Former US Surgeon General
32
Medication Use Continuum33
Osterberg, L. et al. N Engl J Med 2005;353:487-497
Adherence to Medication
According to Frequency of Doses
34

More Related Content

What's hot

Pharmacotherapy of Heart Failure
Pharmacotherapy of Heart FailurePharmacotherapy of Heart Failure
Pharmacotherapy of Heart Failure
Dr. Ashutosh Tiwari
 
Hypertension
HypertensionHypertension
Hypertension
samirelansary
 
Hypertension
HypertensionHypertension
Hypertension
ashafernandes4
 
Hypertension guidelines comparison.pptx
Hypertension guidelines comparison.pptxHypertension guidelines comparison.pptx
Hypertension guidelines comparison.pptx
desktoppc
 
Hypertension
HypertensionHypertension
Hypertension
Nandkishor Jha
 
Telmisartan combination uses
Telmisartan combination usesTelmisartan combination uses
Telmisartan combination uses
BALASUBRAMANIAM IYER
 
Ppt on hypertension
Ppt on hypertensionPpt on hypertension
Ppt on hypertension
pawan kumar
 
Angina pectoris
Angina pectorisAngina pectoris
Angina pectoris
Akshu Agrawal
 
Hypertension
HypertensionHypertension
Hypertension
Ruchita Bhavsar
 
Angiotensin receptor blockers
Angiotensin receptor blockersAngiotensin receptor blockers
Angiotensin receptor blockers
Mahatma Gandhi Medical College & Hospital
 
Pharmacotherapy of hypertension
Pharmacotherapy of hypertensionPharmacotherapy of hypertension
Pharmacotherapy of hypertension
Dr Shahid Saache
 
Hypertension Guidelines JNC 8
Hypertension Guidelines JNC 8Hypertension Guidelines JNC 8
Hypertension Guidelines JNC 8
nik_sat
 
Hypertension by Dr. Mohib Ali
Hypertension by Dr. Mohib AliHypertension by Dr. Mohib Ali
Hypertension by Dr. Mohib Ali
Mohib Ali
 
Anti hypertensives
Anti hypertensivesAnti hypertensives
Anti hypertensives
Aman Hassan
 
Hypertension
Hypertension Hypertension
Hypertension
Baljinder Singh
 
Hyperlipidemia
HyperlipidemiaHyperlipidemia
Hyperlipidemia
Jaineel Dharod
 
Pharmacotherapy of dyslipidemia
Pharmacotherapy of dyslipidemiaPharmacotherapy of dyslipidemia
Pharmacotherapy of dyslipidemia
Dr. Irfan Ahmad Khan
 
Beta blockers: Role in Hypertension
Beta blockers: Role in HypertensionBeta blockers: Role in Hypertension
Beta blockers: Role in Hypertension
Sujay Iyer
 
Antihypertensive mbbs copy
Antihypertensive mbbs   copyAntihypertensive mbbs   copy
Antihypertensive mbbs copy
Divya Krishnan
 

What's hot (20)

Pharmacotherapy of Heart Failure
Pharmacotherapy of Heart FailurePharmacotherapy of Heart Failure
Pharmacotherapy of Heart Failure
 
Hypertension
HypertensionHypertension
Hypertension
 
Hypertension
HypertensionHypertension
Hypertension
 
Hypertension guidelines comparison.pptx
Hypertension guidelines comparison.pptxHypertension guidelines comparison.pptx
Hypertension guidelines comparison.pptx
 
Hypertension
HypertensionHypertension
Hypertension
 
Telmisartan combination uses
Telmisartan combination usesTelmisartan combination uses
Telmisartan combination uses
 
Ppt on hypertension
Ppt on hypertensionPpt on hypertension
Ppt on hypertension
 
Angina pectoris
Angina pectorisAngina pectoris
Angina pectoris
 
Hypertension
HypertensionHypertension
Hypertension
 
Angiotensin receptor blockers
Angiotensin receptor blockersAngiotensin receptor blockers
Angiotensin receptor blockers
 
Pharmacotherapy of hypertension
Pharmacotherapy of hypertensionPharmacotherapy of hypertension
Pharmacotherapy of hypertension
 
Hypertension Guidelines JNC 8
Hypertension Guidelines JNC 8Hypertension Guidelines JNC 8
Hypertension Guidelines JNC 8
 
Hypertension by Dr. Mohib Ali
Hypertension by Dr. Mohib AliHypertension by Dr. Mohib Ali
Hypertension by Dr. Mohib Ali
 
Anti hypertensives
Anti hypertensivesAnti hypertensives
Anti hypertensives
 
Hypertension
HypertensionHypertension
Hypertension
 
Hypertension
Hypertension Hypertension
Hypertension
 
Hyperlipidemia
HyperlipidemiaHyperlipidemia
Hyperlipidemia
 
Pharmacotherapy of dyslipidemia
Pharmacotherapy of dyslipidemiaPharmacotherapy of dyslipidemia
Pharmacotherapy of dyslipidemia
 
Beta blockers: Role in Hypertension
Beta blockers: Role in HypertensionBeta blockers: Role in Hypertension
Beta blockers: Role in Hypertension
 
Antihypertensive mbbs copy
Antihypertensive mbbs   copyAntihypertensive mbbs   copy
Antihypertensive mbbs copy
 

Viewers also liked

Treatment of Hypertension Treatment of Hypertension
Treatment of Hypertension 	 Treatment of HypertensionTreatment of Hypertension 	 Treatment of Hypertension
Treatment of Hypertension Treatment of HypertensionMedicineAndHealthCancer
 
Antihypertensive drugs
Antihypertensive drugs  Antihypertensive drugs
Antihypertensive drugs
abhayasreekantannair
 
Pharmacology Handbook for Clinical Practice Show
Pharmacology Handbook for Clinical Practice ShowPharmacology Handbook for Clinical Practice Show
Pharmacology Handbook for Clinical Practice Show
AbdulQadir Nashwan
 
Ten,sjs
Ten,sjsTen,sjs
Ten,sjs
Alekhya Devi
 
Accerlerated hypertension
Accerlerated hypertensionAccerlerated hypertension
Accerlerated hypertensionSachin Verma
 
Passa2
Passa2Passa2
Passa2
Deep Passa
 
Chronic kidney disease
Chronic kidney diseaseChronic kidney disease
Chronic kidney disease
THUSHARA MOHAN
 
Antihypertension / dental courses
Antihypertension / dental coursesAntihypertension / dental courses
Antihypertension / dental courses
Indian dental academy
 
Importance of iron deficiency in asian patients with heart failure
Importance of iron deficiency in asian patients with heart failureImportance of iron deficiency in asian patients with heart failure
Importance of iron deficiency in asian patients with heart failure
drucsamal
 
The Effects of Obstructive Sleep Apnea and Visceral Fat on Insulin Resistance
The Effects of Obstructive Sleep Apnea and Visceral Fat on Insulin ResistanceThe Effects of Obstructive Sleep Apnea and Visceral Fat on Insulin Resistance
The Effects of Obstructive Sleep Apnea and Visceral Fat on Insulin Resistance
Biomedical Statistical Consulting
 
JNC 8
JNC 8JNC 8
New Hypertension Guidelines
New Hypertension GuidelinesNew Hypertension Guidelines
New Hypertension Guidelines
magdy elmasry
 
Dry, broken skin on hands
Dry, broken skin on handsDry, broken skin on hands
Dry, broken skin on hands
Nutt So Ruff, LLC
 
Ueda2016 workshop - hypoglycemia1 -lobna el toony
Ueda2016 workshop - hypoglycemia1 -lobna el toonyUeda2016 workshop - hypoglycemia1 -lobna el toony
Ueda2016 workshop - hypoglycemia1 -lobna el toony
ueda2015
 
ueda2012 do we still need high doses-d.mohammed
ueda2012 do we still need high doses-d.mohammedueda2012 do we still need high doses-d.mohammed
ueda2012 do we still need high doses-d.mohammed
ueda2015
 
Anaemia in heart failure
Anaemia in heart failureAnaemia in heart failure
Anaemia in heart failure
drabhishekbabbu
 
Ueda2016 new horizon in the management of dyslipidemia - diaa ewais
Ueda2016 new horizon in the management of dyslipidemia - diaa ewaisUeda2016 new horizon in the management of dyslipidemia - diaa ewais
Ueda2016 new horizon in the management of dyslipidemia - diaa ewais
ueda2015
 

Viewers also liked (20)

Treatment of Hypertension Treatment of Hypertension
Treatment of Hypertension 	 Treatment of HypertensionTreatment of Hypertension 	 Treatment of Hypertension
Treatment of Hypertension Treatment of Hypertension
 
Antihypertensive drugs
Antihypertensive drugs  Antihypertensive drugs
Antihypertensive drugs
 
Drug therapy for heart failure
Drug therapy for heart failureDrug therapy for heart failure
Drug therapy for heart failure
 
Pharmacology Handbook for Clinical Practice Show
Pharmacology Handbook for Clinical Practice ShowPharmacology Handbook for Clinical Practice Show
Pharmacology Handbook for Clinical Practice Show
 
Ten,sjs
Ten,sjsTen,sjs
Ten,sjs
 
Accerlerated hypertension
Accerlerated hypertensionAccerlerated hypertension
Accerlerated hypertension
 
Passa2
Passa2Passa2
Passa2
 
Chronic kidney disease
Chronic kidney diseaseChronic kidney disease
Chronic kidney disease
 
Antihypertension / dental courses
Antihypertension / dental coursesAntihypertension / dental courses
Antihypertension / dental courses
 
Importance of iron deficiency in asian patients with heart failure
Importance of iron deficiency in asian patients with heart failureImportance of iron deficiency in asian patients with heart failure
Importance of iron deficiency in asian patients with heart failure
 
The Effects of Obstructive Sleep Apnea and Visceral Fat on Insulin Resistance
The Effects of Obstructive Sleep Apnea and Visceral Fat on Insulin ResistanceThe Effects of Obstructive Sleep Apnea and Visceral Fat on Insulin Resistance
The Effects of Obstructive Sleep Apnea and Visceral Fat on Insulin Resistance
 
JNC 8
JNC 8JNC 8
JNC 8
 
Substance abuse treatment
Substance abuse treatmentSubstance abuse treatment
Substance abuse treatment
 
New Hypertension Guidelines
New Hypertension GuidelinesNew Hypertension Guidelines
New Hypertension Guidelines
 
Dry, broken skin on hands
Dry, broken skin on handsDry, broken skin on hands
Dry, broken skin on hands
 
Ueda2016 workshop - hypoglycemia1 -lobna el toony
Ueda2016 workshop - hypoglycemia1 -lobna el toonyUeda2016 workshop - hypoglycemia1 -lobna el toony
Ueda2016 workshop - hypoglycemia1 -lobna el toony
 
Iron therapies
Iron therapiesIron therapies
Iron therapies
 
ueda2012 do we still need high doses-d.mohammed
ueda2012 do we still need high doses-d.mohammedueda2012 do we still need high doses-d.mohammed
ueda2012 do we still need high doses-d.mohammed
 
Anaemia in heart failure
Anaemia in heart failureAnaemia in heart failure
Anaemia in heart failure
 
Ueda2016 new horizon in the management of dyslipidemia - diaa ewais
Ueda2016 new horizon in the management of dyslipidemia - diaa ewaisUeda2016 new horizon in the management of dyslipidemia - diaa ewais
Ueda2016 new horizon in the management of dyslipidemia - diaa ewais
 

Similar to Hypertension principle of drug therapy

Understanding hypertension
Understanding hypertensionUnderstanding hypertension
Understanding hypertension
Reynel Dan
 
Overview of the Medical Management of High Blood Pressure in Adults
Overview of the Medical Management of High Blood Pressure in AdultsOverview of the Medical Management of High Blood Pressure in Adults
Overview of the Medical Management of High Blood Pressure in Adults
Luis Daniel Lugo
 
CARDIOVASCULAR PHARMACOLOGY.ppt
CARDIOVASCULAR PHARMACOLOGY.pptCARDIOVASCULAR PHARMACOLOGY.ppt
CARDIOVASCULAR PHARMACOLOGY.ppt
MulatuAsfaw
 
Essential Hypertension
Essential Hypertension Essential Hypertension
Essential Hypertension
raheef
 
Heart Failure- Clinical Therapeutics
Heart Failure- Clinical TherapeuticsHeart Failure- Clinical Therapeutics
Heart Failure- Clinical Therapeutics
Timothy Zagada
 
Treatment Of Hypertension In Special Situation Modified Fina Lc
Treatment Of Hypertension In Special Situation Modified Fina LcTreatment Of Hypertension In Special Situation Modified Fina Lc
Treatment Of Hypertension In Special Situation Modified Fina Lcdrmisbah83
 
Drug Prescription in hypertension
Drug Prescription in hypertension Drug Prescription in hypertension
Drug Prescription in hypertension
Nehal M. Ramadan
 
Anti htn drugs
Anti htn drugsAnti htn drugs
Anti htn drugs
DrVishal Kandhway
 
Combination Therapy In Hypertension - Dr Vivek Baliga Presentation
Combination Therapy In Hypertension - Dr Vivek Baliga PresentationCombination Therapy In Hypertension - Dr Vivek Baliga Presentation
Combination Therapy In Hypertension - Dr Vivek Baliga Presentation
Dr Vivek Baliga
 
Antihypertensive Drugs & Diuretics|Pharmacology Assignment 3.1.pdf
Antihypertensive Drugs & Diuretics|Pharmacology Assignment 3.1.pdfAntihypertensive Drugs & Diuretics|Pharmacology Assignment 3.1.pdf
Antihypertensive Drugs & Diuretics|Pharmacology Assignment 3.1.pdf
Md. Shakil Sarker
 
CVS(2).pdf
CVS(2).pdfCVS(2).pdf
CVS(2).pdf
KoangWichyoah
 
Drugs used in hypertension
Drugs used in hypertensionDrugs used in hypertension
Drugs used in hypertension
Goutam Mallik
 
combinatintherapyhypertension-baliga.pdf
combinatintherapyhypertension-baliga.pdfcombinatintherapyhypertension-baliga.pdf
combinatintherapyhypertension-baliga.pdf
AshutoshChaturvedi36
 
Cardiovascular+pharmacology+drug+therapy+of+hypertension
Cardiovascular+pharmacology+drug+therapy+of+hypertensionCardiovascular+pharmacology+drug+therapy+of+hypertension
Cardiovascular+pharmacology+drug+therapy+of+hypertension
Dr.Ebrahim Eltanbouly
 
Pharmacotherapy of heart failure
Pharmacotherapy of heart failurePharmacotherapy of heart failure
Pharmacotherapy of heart failure
Dr. Shivesh Gupta
 
Antihypertensive drugs
Antihypertensive drugsAntihypertensive drugs
Antihypertensive drugs
Damascus University
 
Hypertension
HypertensionHypertension
Hypertension
Tsegaye Melaku
 

Similar to Hypertension principle of drug therapy (20)

Understanding hypertension
Understanding hypertensionUnderstanding hypertension
Understanding hypertension
 
Overview of the Medical Management of High Blood Pressure in Adults
Overview of the Medical Management of High Blood Pressure in AdultsOverview of the Medical Management of High Blood Pressure in Adults
Overview of the Medical Management of High Blood Pressure in Adults
 
CARDIOVASCULAR PHARMACOLOGY.ppt
CARDIOVASCULAR PHARMACOLOGY.pptCARDIOVASCULAR PHARMACOLOGY.ppt
CARDIOVASCULAR PHARMACOLOGY.ppt
 
Essential Hypertension
Essential Hypertension Essential Hypertension
Essential Hypertension
 
Heart Failure- Clinical Therapeutics
Heart Failure- Clinical TherapeuticsHeart Failure- Clinical Therapeutics
Heart Failure- Clinical Therapeutics
 
Treatment Of Hypertension In Special Situation Modified Fina Lc
Treatment Of Hypertension In Special Situation Modified Fina LcTreatment Of Hypertension In Special Situation Modified Fina Lc
Treatment Of Hypertension In Special Situation Modified Fina Lc
 
Drug Prescription in hypertension
Drug Prescription in hypertension Drug Prescription in hypertension
Drug Prescription in hypertension
 
Anti htn drugs
Anti htn drugsAnti htn drugs
Anti htn drugs
 
Combination Therapy In Hypertension - Dr Vivek Baliga Presentation
Combination Therapy In Hypertension - Dr Vivek Baliga PresentationCombination Therapy In Hypertension - Dr Vivek Baliga Presentation
Combination Therapy In Hypertension - Dr Vivek Baliga Presentation
 
Antihypertensive Drugs & Diuretics|Pharmacology Assignment 3.1.pdf
Antihypertensive Drugs & Diuretics|Pharmacology Assignment 3.1.pdfAntihypertensive Drugs & Diuretics|Pharmacology Assignment 3.1.pdf
Antihypertensive Drugs & Diuretics|Pharmacology Assignment 3.1.pdf
 
CVS(2).pdf
CVS(2).pdfCVS(2).pdf
CVS(2).pdf
 
Drugs used in hypertension
Drugs used in hypertensionDrugs used in hypertension
Drugs used in hypertension
 
combinatintherapyhypertension-baliga.pdf
combinatintherapyhypertension-baliga.pdfcombinatintherapyhypertension-baliga.pdf
combinatintherapyhypertension-baliga.pdf
 
Hypertension
HypertensionHypertension
Hypertension
 
Hypertension
HypertensionHypertension
Hypertension
 
Cardiovascular+pharmacology+drug+therapy+of+hypertension
Cardiovascular+pharmacology+drug+therapy+of+hypertensionCardiovascular+pharmacology+drug+therapy+of+hypertension
Cardiovascular+pharmacology+drug+therapy+of+hypertension
 
Antihypertensive lecture
Antihypertensive lecture Antihypertensive lecture
Antihypertensive lecture
 
Pharmacotherapy of heart failure
Pharmacotherapy of heart failurePharmacotherapy of heart failure
Pharmacotherapy of heart failure
 
Antihypertensive drugs
Antihypertensive drugsAntihypertensive drugs
Antihypertensive drugs
 
Hypertension
HypertensionHypertension
Hypertension
 

More from University of Florida

Lupus nephritis
Lupus nephritisLupus nephritis
Lupus nephritis
University of Florida
 
Gestational hypertension
Gestational hypertensionGestational hypertension
Gestational hypertension
University of Florida
 
Hypertension non pharmcolical management
Hypertension   non pharmcolical managementHypertension   non pharmcolical management
Hypertension non pharmcolical managementUniversity of Florida
 
Ancient israelites
Ancient israelitesAncient israelites
Ancient israelites
University of Florida
 

More from University of Florida (17)

Lupus nephritis
Lupus nephritisLupus nephritis
Lupus nephritis
 
Hypertension neonatal
Hypertension   neonatalHypertension   neonatal
Hypertension neonatal
 
Pediatric hypertension
Pediatric hypertensionPediatric hypertension
Pediatric hypertension
 
Gestational hypertension
Gestational hypertensionGestational hypertension
Gestational hypertension
 
Hypertension and renal diseases
Hypertension and renal diseasesHypertension and renal diseases
Hypertension and renal diseases
 
Hypertension and obesity
Hypertension and obesityHypertension and obesity
Hypertension and obesity
 
Hypertension drug therapy
Hypertension   drug therapyHypertension   drug therapy
Hypertension drug therapy
 
Hypertension non pharmcolical management
Hypertension   non pharmcolical managementHypertension   non pharmcolical management
Hypertension non pharmcolical management
 
Hypertensive emergencies
Hypertensive emergenciesHypertensive emergencies
Hypertensive emergencies
 
Hypertension sequel - 2
Hypertension   sequel - 2Hypertension   sequel - 2
Hypertension sequel - 2
 
Hypertension sequel 1
Hypertension   sequel 1Hypertension   sequel 1
Hypertension sequel 1
 
Hypertension evaluation 2
Hypertension   evaluation 2Hypertension   evaluation 2
Hypertension evaluation 2
 
Hypertension evaluation 1
Hypertension   evaluation 1Hypertension   evaluation 1
Hypertension evaluation 1
 
Hypertension BP mesurement
Hypertension   BP mesurementHypertension   BP mesurement
Hypertension BP mesurement
 
Hypertension regulation
Hypertension   regulationHypertension   regulation
Hypertension regulation
 
Hypertension introduction
Hypertension   introductionHypertension   introduction
Hypertension introduction
 
Ancient israelites
Ancient israelitesAncient israelites
Ancient israelites
 

Recently uploaded

Students, digital devices and success - Andreas Schleicher - 27 May 2024..pptx
Students, digital devices and success - Andreas Schleicher - 27 May 2024..pptxStudents, digital devices and success - Andreas Schleicher - 27 May 2024..pptx
Students, digital devices and success - Andreas Schleicher - 27 May 2024..pptx
EduSkills OECD
 
special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
Special education needs
 
Ethnobotany and Ethnopharmacology ......
Ethnobotany and Ethnopharmacology ......Ethnobotany and Ethnopharmacology ......
Ethnobotany and Ethnopharmacology ......
Ashokrao Mane college of Pharmacy Peth-Vadgaon
 
Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
DeeptiGupta154
 
Template Jadual Bertugas Kelas (Boleh Edit)
Template Jadual Bertugas Kelas (Boleh Edit)Template Jadual Bertugas Kelas (Boleh Edit)
Template Jadual Bertugas Kelas (Boleh Edit)
rosedainty
 
How to Split Bills in the Odoo 17 POS Module
How to Split Bills in the Odoo 17 POS ModuleHow to Split Bills in the Odoo 17 POS Module
How to Split Bills in the Odoo 17 POS Module
Celine George
 
MARUTI SUZUKI- A Successful Joint Venture in India.pptx
MARUTI SUZUKI- A Successful Joint Venture in India.pptxMARUTI SUZUKI- A Successful Joint Venture in India.pptx
MARUTI SUZUKI- A Successful Joint Venture in India.pptx
bennyroshan06
 
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXXPhrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
MIRIAMSALINAS13
 
How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...
Jisc
 
The Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdfThe Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdf
kaushalkr1407
 
Fish and Chips - have they had their chips
Fish and Chips - have they had their chipsFish and Chips - have they had their chips
Fish and Chips - have they had their chips
GeoBlogs
 
Unit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdfUnit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdf
Thiyagu K
 
PART A. Introduction to Costumer Service
PART A. Introduction to Costumer ServicePART A. Introduction to Costumer Service
PART A. Introduction to Costumer Service
PedroFerreira53928
 
GIÁO ÁN DẠY THÊM (KẾ HOẠCH BÀI BUỔI 2) - TIẾNG ANH 8 GLOBAL SUCCESS (2 CỘT) N...
GIÁO ÁN DẠY THÊM (KẾ HOẠCH BÀI BUỔI 2) - TIẾNG ANH 8 GLOBAL SUCCESS (2 CỘT) N...GIÁO ÁN DẠY THÊM (KẾ HOẠCH BÀI BUỔI 2) - TIẾNG ANH 8 GLOBAL SUCCESS (2 CỘT) N...
GIÁO ÁN DẠY THÊM (KẾ HOẠCH BÀI BUỔI 2) - TIẾNG ANH 8 GLOBAL SUCCESS (2 CỘT) N...
Nguyen Thanh Tu Collection
 
Operation Blue Star - Saka Neela Tara
Operation Blue Star   -  Saka Neela TaraOperation Blue Star   -  Saka Neela Tara
Operation Blue Star - Saka Neela Tara
Balvir Singh
 
The Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official PublicationThe Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official Publication
Delapenabediema
 
The approach at University of Liverpool.pptx
The approach at University of Liverpool.pptxThe approach at University of Liverpool.pptx
The approach at University of Liverpool.pptx
Jisc
 
Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345
beazzy04
 
Cambridge International AS A Level Biology Coursebook - EBook (MaryFosbery J...
Cambridge International AS  A Level Biology Coursebook - EBook (MaryFosbery J...Cambridge International AS  A Level Biology Coursebook - EBook (MaryFosbery J...
Cambridge International AS A Level Biology Coursebook - EBook (MaryFosbery J...
AzmatAli747758
 
Thesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.pptThesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.ppt
EverAndrsGuerraGuerr
 

Recently uploaded (20)

Students, digital devices and success - Andreas Schleicher - 27 May 2024..pptx
Students, digital devices and success - Andreas Schleicher - 27 May 2024..pptxStudents, digital devices and success - Andreas Schleicher - 27 May 2024..pptx
Students, digital devices and success - Andreas Schleicher - 27 May 2024..pptx
 
special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
 
Ethnobotany and Ethnopharmacology ......
Ethnobotany and Ethnopharmacology ......Ethnobotany and Ethnopharmacology ......
Ethnobotany and Ethnopharmacology ......
 
Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
 
Template Jadual Bertugas Kelas (Boleh Edit)
Template Jadual Bertugas Kelas (Boleh Edit)Template Jadual Bertugas Kelas (Boleh Edit)
Template Jadual Bertugas Kelas (Boleh Edit)
 
How to Split Bills in the Odoo 17 POS Module
How to Split Bills in the Odoo 17 POS ModuleHow to Split Bills in the Odoo 17 POS Module
How to Split Bills in the Odoo 17 POS Module
 
MARUTI SUZUKI- A Successful Joint Venture in India.pptx
MARUTI SUZUKI- A Successful Joint Venture in India.pptxMARUTI SUZUKI- A Successful Joint Venture in India.pptx
MARUTI SUZUKI- A Successful Joint Venture in India.pptx
 
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXXPhrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
 
How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...
 
The Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdfThe Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdf
 
Fish and Chips - have they had their chips
Fish and Chips - have they had their chipsFish and Chips - have they had their chips
Fish and Chips - have they had their chips
 
Unit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdfUnit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdf
 
PART A. Introduction to Costumer Service
PART A. Introduction to Costumer ServicePART A. Introduction to Costumer Service
PART A. Introduction to Costumer Service
 
GIÁO ÁN DẠY THÊM (KẾ HOẠCH BÀI BUỔI 2) - TIẾNG ANH 8 GLOBAL SUCCESS (2 CỘT) N...
GIÁO ÁN DẠY THÊM (KẾ HOẠCH BÀI BUỔI 2) - TIẾNG ANH 8 GLOBAL SUCCESS (2 CỘT) N...GIÁO ÁN DẠY THÊM (KẾ HOẠCH BÀI BUỔI 2) - TIẾNG ANH 8 GLOBAL SUCCESS (2 CỘT) N...
GIÁO ÁN DẠY THÊM (KẾ HOẠCH BÀI BUỔI 2) - TIẾNG ANH 8 GLOBAL SUCCESS (2 CỘT) N...
 
Operation Blue Star - Saka Neela Tara
Operation Blue Star   -  Saka Neela TaraOperation Blue Star   -  Saka Neela Tara
Operation Blue Star - Saka Neela Tara
 
The Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official PublicationThe Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official Publication
 
The approach at University of Liverpool.pptx
The approach at University of Liverpool.pptxThe approach at University of Liverpool.pptx
The approach at University of Liverpool.pptx
 
Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345
 
Cambridge International AS A Level Biology Coursebook - EBook (MaryFosbery J...
Cambridge International AS  A Level Biology Coursebook - EBook (MaryFosbery J...Cambridge International AS  A Level Biology Coursebook - EBook (MaryFosbery J...
Cambridge International AS A Level Biology Coursebook - EBook (MaryFosbery J...
 
Thesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.pptThesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.ppt
 

Hypertension principle of drug therapy

  • 1. HYPERTENSION Principle of Drug Therapy Mohammad Ilyas, M.D. Assistant Clinical Professor University of Florida / Health Sciences Center Jacksonville, Florida USA 1
  • 2. Why Treat HTN? All Symptomatic patients, treatment is Mandatory: Damage to the vascular epithelium, paving the path for atherosclerosis (IHD, CVA) or nephropathy due to high intra-glomerular pressure Reduction of the blood pressure by 5 mmHg can decrease the risk of stroke by 34%, of ischaemic heart disease by 21%. Hypertension, even asymptomatic needs treatment 2
  • 3. Types of Hypertension Essential Secondary A disorder of unknown origin affecting the Blood Pressure regulating mechanisms Secondary to other disease processes Environmental Factors Stress Na+ Intake Obesity Smoking 3
  • 4. Risk factors for CVD 1. Age above 55 and 65 in Men and Woman respectively 2. Family History 3. Smoking 4. DM and Dyslipidemia 5. Hypertension 6. Obesity 7. Microalbuminuria 4
  • 5. JNC 7 (2003) Hypertension Classification and Management 5
  • 6. JAMA. 2013;():. doi:10.1001/jama.2013.284427 JNC 8 (2014 Hypertension Guideline Management Algorithm) 2 6
  • 7. JAMA. 2013;():. doi:10.1001/jama.2013.284427 JNC 8 (2014 Hypertension Guideline Management Algorithm) 7
  • 8. Blood Pressure Regulation  Blood Pressure = Cardiac output (CO) X Resistance to passage of blood through pre-capillary arterioles (PVR)  Physiologically CO and PVR is maintained minute to minute by – arterioles (1) post-capillary venules (2) and Heart (3)  Kidney is the fourth site – volume of intravascular fluid  Baroreflex, humoral mechanism and renin-angiotensin- aldosterone system regulates the above 4 sites  Local agents like Nitric oxide  In hypertensives – Baroreflex and renal blood-volume control system – set at higher level  All antihypertensives act via interfering with normal mechanisms 8
  • 9. 9
  • 10. Baroreceptor reflex arc  Postural baroreflex: 10
  • 11. The Renal response  Long-term blood pressure control – by controlling blood volume  Reduction in renal pressure - intrarenal redistribution of pressure and increased absorption of salt and water  Decreased pressure in renal arterioles and sympathetic activity – renin production – angiotensin II production  Angiotensin II: Causes direct constriction of renal arterioles Stimulation of aldosterone synthesis – sodium absorption and increase in intravascular blood volume 11
  • 12. 12
  • 13. Start one drug, titrate to maximum dose, and then add a second drug Start one drug and then add a second drug before achieving maximum dose of the initial drug Begin with 2 drugs at the same time, either as 2 separate pills or as a single pill combination Strategies to Dose of Antihypertensive Drugs13
  • 14. Principle of Pharmacologic Therapy Initial mono-therapy in uncomplicated hypertension Thiazide diuretics, long-acting calcium channel blockers and ACE inhibitors or angiotensin II receptor blockers. Beta blockers are not commonly used for initial mono therapy in the absence of a specific indication Combination therapy - with drugs from different classes has a substantially greater blood pressure lowering effect than doubling the dose of a single agent. 14
  • 15. Pre-hypertension Individuals who are pre-hypertensive are not candidates for drug therapy but  Should be firmly and unambiguously advised to practice lifestyle modification Those with pre-HTN, who also have diabetes or kidney disease, drug therapy is indicated if a trial of lifestyle modification fails to reduce their BP to 130/80 mmHg or less. 15
  • 16. Isolated Systolic Hypertension Not distinguished as a separate entity as far as management is concerned. SBP should be primarily considered during treatment and not just diastolic BP. Systolic BP is more important cardiovascular risk factor after age 50. Diastolic BP is more important before age 50. 16
  • 17. Frequency Distribution of Untreated HTN by Age17 Isolated Systolic HTN Isolated Diastolic HTN Systolic Diastolic HTN
  • 18. Treatment of Hypertension 7 compelling Indications: Heart failure Coronary artery disease H/o MI H/o stroke Diabetes Chronic Renal failure 18
  • 19. You must know  Classification of Antihypertensive  Antihypertensive mechanisms: Diuretics, ACE inhibitors, ARBs, Beta-blockers, alpha-blockers, CCBs, Vasodilators and central sympatholytics  Pateint status of Drugs  Preparation and dosage of commonly used drugs.  Common Adverse effects of Drugs 19
  • 20. General principles Stage I: Start with a single most appropriate drug with a low dose. Preferably start with Thiazides. Others like beta-blockers, CCBs, ARBs and ACE inhibitors may also be considered. CCB – in case of elderly and stroke prevention. If required increase the dose moderately Partial response or no response – add from another group of drug, but remember it should be a low dose combination If not controlled – change to another low dose combination In case of side effects lower the dose or substitute with other group Stage 2: Start with 2 drug combination – one should be diuretic 20
  • 21. Combination therapy  In clinical practice a large number of patients require combination therapy – the combination should be rational and from different patterns of haemodynamic effects Sympathetic inhibitors (not beta-blockers) and vasodilators + diuretics Diuretics, CCBs, ACE inhibitors and vasodilators + beta blockers (blocks renin release) Hydralazine and CCBs + beta-blockers (tachycardia countered) ACE inhibitors + diuretics  3 (three) Drug combinations: CCB+ACE/ARB+diuretic; CCB+Beta blocker+ diuretic; ACEI/ARB+ beta blocker+diuretic 21
  • 22. Principle of Combination  Never combine: Alpha or beta blocker and clonidine - antagonism Nifedepine and diuretic synergism Hydralazine with prazosin Diltiazem and verapamil with beta blocker – bradycardia Methyldopa and clonidine  Hypertension and pregnancy: No drug is safe in pregnancy Avoid diuretics, propranolol, ACE inhibitors, Sodium nitroprusside etc Safer drugs: Hydralazine, Methyldopa, cardioselective beta blockers and prazosin 22
  • 23. Nocturnal therapy  The average nocturnal blood pressure is approximately 15 percent lower than daytime values.  Failure of the blood pressure to fall by at least 10 percent during sleep is called "non-dipping," and is a stronger predictor of adverse cardiovascular outcomes than daytime blood pressure.  Shifting at least one antihypertensive medication from the morning to the evening both may restore the normal nocturnal blood pressure dip, and reduces 24-hour mean blood pressure.  Nocturnal antihypertensive therapy may reduce the incidence of cardiovascular disease 23
  • 24. Resistant hypertension Resistance is usually defined as a diastolic blood pressure above 90 mmHg despite intake of three or more antihypertensive medications including a diuretic.  Suboptimal therapy  Extracellular volume expansion  Poor compliance with medical or dietary therapy  Identifiable or secondary hypertension  Office or "white coat" hypertension  Ingestion of substances that can elevate the blood pressure 24
  • 25. Individualizing antihypertensive therapy Indication Antihypertensive drugs Systolic heart failure ACE inhibitor or ARB, beta blocker, diuretic, aldosterone antagonist* Post-myocardial infarction ACE inhibitor, beta blocker, ARB, aldosterone antagonist Proteinuric kidney disease ACE inhibitor and/or ARB Angina pectoris Beta blocker, calcium channel blocker Atrial fibrillation rate control Beta blocker, non-dihydropyridine calcium channel blocker Atrial flutter rate control Beta blocker, non-dihydropyridine calcium channel blocker 25
  • 26. Individualizing antihypertensive therapy Benign prostatic hyperplasia Alpha blocker Essential tremor Beta blocker (noncardioselective) Hyperthyroidism Beta blocker Migraine Beta blocker, calcium channel blocker Osteoporosis Thiazide diuretic Raynaud's syndrome Dihydropyridine calcium channel blocker 26
  • 27. Contraindications Angioedema ACE inhibitor Bronchospastic disease Beta blocker Depression Reserpine Liver disease Methyldopa Pregnancy (or at risk for) ACE inhibitor, ARB, renin inhibitor Second or third degree heart block Beta blocker, non- dihydropyridine calcium channel blocker 27
  • 28. Adverse effect Depression Beta blocker, central alpha-2 agonist Gout Diuretic Hyperkalemia Aldosterone antagonist, ACE inhibitor, ARB, renin inhibitor Hyponatremia Thiazide diuretic Renovascular disease ACE inhibitor, ARB, or renin inhibitor 28
  • 29. Discontinuing therapy  If the BP is well control on monotherapy  55 % of patients remain normotensive for at least one to two years  More gradual tapering of drug dose is indicated in well-controlled patients taking multiple drugs  Abrupt cessation of therapy with a short-acting beta-blocker (such as propranolol) or the short-acting alpha-2-agonist clonidine can lead to a potentially fatal withdrawal syndrome.  Gradual discontinuation of these agents over a period of weeks should prevent this problem. 29
  • 30. Pearls The only thiazide that will work with an elevated creatinine is metolazone (zaroxolyn) If creatinine is elevated than use a loop diuretic If potassium is elevated, evaluate current meds and use a diuretic If potassium is low – ask why If edema present – and ask why Elderly patients benefit from blood pressure management Black patients benefit from ACE/ARB – may need to use larger doses to obtain BP lowering effect 30
  • 31. Pearls Cont. Metabolic acidosis and hyperkalemai? Take blood pressure periodically lying and standing so as not to miss supine (orthostatic) hypertension associated with autonomic insufficiency – this is treated differently 31
  • 32. Treatment failure – Why ? “Drugs don’t work in patients who don’t take them” C. Everett Koop, MD, Former US Surgeon General 32
  • 34. Osterberg, L. et al. N Engl J Med 2005;353:487-497 Adherence to Medication According to Frequency of Doses 34